Literature DB >> 17307064

Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy.

Frederick A Masoudi1, Silvio E Inzucchi.   

Abstract

Diabetes mellitus and heart failure (HF), both of which are associated with high rates of adverse cardiovascular outcomes, commonly coexist. Given the marked increases in diabetes prevalence in developed countries, the proportion of the population with both conditions is likely to increase substantially. This article reviews the epidemiology of HF and diabetes, the mechanisms whereby diabetes causes HF, and the pharmacotherapy of both HF and diabetes. Specific challenges in treating patients with both HF and diabetes are also addressed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17307064     DOI: 10.1016/j.amjcard.2006.11.013

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  30 in total

1.  Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal:  Diabetologia       Date:  2012-04-20       Impact factor: 10.122

2.  Educational needs for improving self-care in heart failure patients with diabetes.

Authors:  EunSeok Cha; Patricia C Clark; Carolyn Miller Reilly; Melinda Higgins; Maureen Lobb; Andrew L Smith; Sandra B Dunbar
Journal:  Diabetes Educ       Date:  2012-06-20       Impact factor: 2.140

Review 3.  Heart failure risk and major cardiovascular events in diabetes: an overview of within-group differences in non-insulin antidiabetic treatment.

Authors:  Paola Terlizzese; Fabrizio Losurdo; Massimo Iacoviello; Nadia Aspromonte
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

4.  Generating double knockout mice to model genetic intervention for diabetic cardiomyopathy in humans.

Authors:  Vishalakshi Chavali; Shyam Sundar Nandi; Shree Ram Singh; Paras Kumar Mishra
Journal:  Methods Mol Biol       Date:  2014

Review 5.  Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review.

Authors:  Dean T Eurich; Finlay A McAlister; David F Blackburn; Sumit R Majumdar; Ross T Tsuyuki; Janice Varney; Jeffrey A Johnson
Journal:  BMJ       Date:  2007-08-30

6.  A pilot test of an integrated self-care intervention for persons with heart failure and concomitant diabetes.

Authors:  Sandra B Dunbar; Brittany Butts; Carolyn M Reilly; Rebecca A Gary; Melinda K Higgins; Erin P Ferranti; Steven D Culler; Javed Butler
Journal:  Nurs Outlook       Date:  2013-10-02       Impact factor: 3.250

7.  Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database.

Authors:  Michael R MacDonald; Dean T Eurich; Sumit R Majumdar; James D Lewsey; Sai Bhagra; Pardeep S Jhund; Mark C Petrie; John J V McMurray; John R Petrie; Finlay A McAlister
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 17.152

8.  Diabetes and heart failure in patients with coronary disease: separating markers from mediators.

Authors:  Darren K McGuire; M Odette Gore; Frederick A Masoudi
Journal:  Diabetes Care       Date:  2010-09       Impact factor: 17.152

Review 9.  Metabolic dysfunction in diabetic cardiomyopathy.

Authors:  Michael Isfort; Sarah C W Stevens; Stephen Schaffer; Chian Ju Jong; Loren E Wold
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

10.  Hypercholesterolemia and myocardial function evaluated via tissue doppler imaging.

Authors:  Jack Rubinstein; Augusta Pelosi; Ameeth Vedre; Pavan Kotaru; George S Abela
Journal:  Cardiovasc Ultrasound       Date:  2009-11-27       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.